7 products found
Valeo Pharma Inc. Products
-
Respiratory
Asthma is a chronic inflammatory disease that causes the airways in the lungs to narrow and swell. Symptoms include wheezing, breathlessness, chest tightness, cough and asthma attacks (exacerbations). At Valeo Pharma we are launching novel asthma medications so that as Canadians we can do better.
-
Enerzair - Breezhaler
Asthma is a chronic inflammatory disease that causes the airways in the lungs to narrow and swell. Symptoms include wheezing, breathlessness, chest tightness, cough and asthma attacks ...
-
Atectura - Breezhaler
Next generation dual therapy LABA/ICS. Partner with Novartis Pharma ...
-
Specialty Products
Valeo Pharma’s Specialty Products Business Unit is focused on providing Canadian healthcare professionals and patients with innovative hospital specialty products. RedescaTM, it’s leading specialty product, is a Low Molecular Weight Heparin, an injectable anticoagulant drug used primarily to treat and prevent deep vein thrombosis and pulmonary embolism. Valeo also commercialize additional hospital specialty products.
-
Redesca - Enoxaparin Sodium Solution for Injection
RedescaTM is the only heparin biosimilar that is clinically tested, has the largest global patient exposure, and that supprts affordability (health ...
-
M-Eslon - Narcotic Analgesic
M-Eslon is a narcotic analgesic distributed by Valeo Pharma in Canada through a license from Ethypharm ...
-
Ametop - Gel
Ametop Gel is indicated for percutaneous local anesthetic to produce anesthesia of the skin prior to venepuncture or venous cannulation, including intravenous injections of ...
-
Neurology
Neurodegenerative diseases encompass a wide range of conditions that result from progressive damage to cells and nervous system connections that are essential for mobility, coordination, strength, sensation, and cognition. Neurodegenerative diseases affect millions of people worldwide and represent a major threat to human health.
-
Onstryv - Safinamide Tablets
The first Parkinson’s Disease (PD) treatment in Canada since 2006, providing relief of symptoms during the off-phase in dopamine treated ...
-
Oncology
Cancer is a complex group of diseases with many possible causes and refers to a large number of diseases characterized by the development of abnormal cells that divide uncontrollably and have the ability to infiltrate and destroy normal body tissue. It is one of the leading cause of death in the world but survival rates are improving for many types of cancer, thanks to improvements in cancer screening, treatment and prevention. Valeo Pharma is responsible for the commercialization of Yondelis in Canada, an important treatment option for patients with soft tissue sarcoma.
-
Yondelis - Model trabectedin - Novel Marine-Derived Antitumor Agent
Yondelis® (trabectedin) is a novel marine-derived antitumor agent manufactured by PharmaMar S.A., based in Madrid, Spain. It exerts its anticancer effects primarily by inhibiting active transcription, a type of gene expression on which proliferating cancer cells are particularly ...